Hulio and Elevated temperature - a phase IV clinical study of FDA data

Summary:

Elevated temperature is reported as a side effect among people who take Hulio (adalimumab-fkjp), especially for people who are female, 40-49 old, have been taking the drug for 6 - 12 months also take Ventolin Hfa, and have Crohn's disease.

The phase IV clinical study analyzes which people have Elevated temperature when taking Hulio. It is created by eHealthMe based on reports of 1,610 people who have side effects when taking Hulio from the FDA, and is updated regularly.

What is Hulio?

Hulio has active ingredients of adalimumab-fkjp. eHealthMe is studying from 1,610 Hulio users. Check the latest studies of Hulio.

What is Elevated temperature?

Elevated temperature (high temperature) is found to be associated with 4,561 drugs and 6,272 conditions by eHealthMe. Check the latest studies of Elevated temperature.

On Jul, 24, 2026

1,610 people reported to have side effects when taking Hulio.
Among them, 39 people (2.42%) have Elevated temperature.

Among these 39 people:

How long have people been on Hulio when they have Elevated temperature? *

What is the gender of people who have Elevated temperature when taking Hulio? *

female: 76.67 %
male: 23.33 %

What is the age of people who have Elevated temperature when taking Hulio? *

What are other drugs people take besides Hulio? *

Actemra: 7 people, 17.95%
Methotrexate: 7 people, 17.95%
Colchicine: 7 people, 17.95%
Synthroid: 7 people, 17.95%
Elavil: 7 people, 17.95%
Esomeprazole Magnesium: 7 people, 17.95%
Ventolin Hfa: 7 people, 17.95%
Dilaudid: 6 people, 15.38%
Leflunomide: 6 people, 15.38%
Medrol: 6 people, 15.38%

What are other side effects people have besides Elevated temperature? *

Pain: 13 people, 33.33%
Rashes (redness): 13 people, 33.33%
Headache (pain in head): 12 people, 30.77%
Diarrhea: 11 people, 28.21%
Fatigue (feeling of tiredness): 9 people, 23.08%
Dyspnea (difficult or laboured breathing): 9 people, 23.08%
Pulmonary Embolism (blockage of the main artery of the lung): 8 people, 20.51%
Lymph Follicular Hypertrophy (an increase in the size of the lymph node follicles): 8 people, 20.51%
Chest Pain: 8 people, 20.51%
Thrombocytopenia (decrease of platelets in blood): 8 people, 20.51%

What are the existing conditions these people have? *

Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 12 people, 30.77%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 10 people, 25.64%
Pain: 6 people, 15.38%
Hidradenitis (chronic disease of a type of sweat gland): 6 people, 15.38%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 6 people, 15.38%
Rashes (redness): 3 people, 7.69%
Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 3 people, 7.69%
Ankylosing Spondylitis (type of arthritis affecting the spine): 3 people, 7.69%
Ulcerative Colitis (inflammatory bowel disease (ibd). it causes swelling, ulcerations, and loss of function of the large intestine): 2 people, 5.13%
Psoriasis (immune-mediated disease that affects the skin): 2 people, 5.13%

* Approximation only. Some reports may have incomplete information.

Do you take Hulio and have Elevated temperature?

- Check whether Elevated temperature is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Hulio:

Hulio (1,610 reports)

Browse all side effects of Hulio:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Elevated temperature:

Elevated temperature (4,561 drugs)

Browse all the conditions that are associated with Elevated temperature:

Elevated temperature (6,272 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on adalimumab-fkjp (the active ingredients of Hulio) and Hulio (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.